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ABSTRACT 
Objectives This study had two objectives. The first was to describe the maternal 
outcomes and complications associated with epidural analgesia and the neonatal 
outcomes of babies born to women receiving intrapartum epidural analgesia. The second 
was to assess the progress of labour in women receiving epidural analgesia and the 
incidence of caesarean section and assisted vaginal deliveries. 
Study design This was a cross sectional retrospective descriptive study of all women 
who received intrapartum epidural analgesia and the neonates born thereof between 
01/05/2015 and 31/10/2015. 
Methods Women who received intrapartum epidural analgesia were identified from the 
epidural registers at the Chris Hani Baragwanath Academic Hospital (CHBAH). The 
medical records of these women and their neonates were retrieved and the relevant data 
reviewed, captured and analysed. 
Results There were a total of 9305 women that delivered between 01/05/2015 and 
31/10/2015, of which 302 received intrapartum epidural analgesia.  The incidence of 
epidural use during this period was 3.24%. The median gestational age at delivery was 
38.9 (37 - 42) weeks’ gestation. The incidence of epidural related complications was 17%, 
comprising of hypotension (13.4%) and other minor complications (3.6%) with no 
associated morbidity or mortality. Eighty-four (29.7%) of the women had poor progress of 
labour pre and post epidural and 13 (4.6%) women post epidural only. Oxytocin for 
augmentation of labour was used in 96 (32.8%) women. The incidence of prolonged 
second stage of labour was 26.9% with an average duration of 63 ±33 minutes, with a 
longer duration observed in primigravid women. 
There were 142 (50.2%) normal vaginal deliveries, 23 (8.1%) assisted vaginal deliveries 
and 118 (41.7%) caesarean sections, of which fetal distress (23%) was the main 
indication. 
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There were a total of 62 cardiotopographs (CTG), that changed from reactive to 
suspicious post epidural, of those 52 neonates were born with an Apgar score of >7. 
Of the 283 neonates delivered, 278 (98.2%) neonates were born alive with 258 (91.2%) 
neonates with Apgar scores of >7 and 23 (8.1%) with Apgar scores <7. The incidence of 
adverse neonatal outcomes was 4.2%. The fetal outcomes stratified by maternal, epidural 
and labour outcomes reflected neither associative nor causal relationship to adverse fetal 
outcomes.  
Conclusion At the CHBAH, intrapartum epidural analgesia uses resulted in a maternal 
complication rate of 17%, with no reported maternal morbidity or mortality. There was no 
statistical increase in the incidence of poor progress of labour, use of oxytocin and 
caesarean section or assisted vaginal deliveries. Two hundred and fifty eight (91.2%) 
neonates were born with Apgar scores of >7, and an adverse neonatal outcome rate of 
4.2%. Therefore the benefits of epidurals analgesia outweigh the risks.  
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1.0 INTRODUCTION AND LITERATURE REVIEW 
Epidural analgesia offers better pain relief than any other method employed to date and is 
the gold standard of analgesia in labour. It provides effective pain management as labour 
progresses, and enables better co-operation from the labouring woman, as it does not 
cause drowsiness. A Cochrane review on the effects of epidural analgesia intrapartum 
showed that it offered better pain relief together with a reduction in the need of additional 
analgesia and a decreased risk of maternal acidosis, but is associated with increased risk 
of assisted vaginal deliveries, maternal hypotension, prolonged second stage of labour 
and oxytocin usage.1 
Neonatal outcomes showed that better pain relief provided by epidurals resulted in a 
decreased incidence of maternal metabolic acidosis, fetal acidosis and Apgar scores <7 
when compared to intravenous opioid analgesia.1 
Since its initiation in 1946, the beneficial effects of epidural analgesia have resulted in an 
increased use throughout the world including developing countries. 
Evaluation of the epidural service at the Chris Hani Baragwanath Academic Hospital 
(CHBAH), in terms of maternal and neonatal outcomes as well as the progress of labour 
will provide valuable insight into factors which may influence pregnancy outcomes and 
hence the need for this study. 
1.1 The history of analgesia use in labour  
Pain management began with simple techniques of distraction, application of warm olive 
oil and herbs to the body and measures such as venesecting women so as to decrease 
blood supply to the brain inducing a coma like state and therefore decreasing the central 
nervous system reaction to pain.2  
During the 1800s, pharmacological interventions resulted in better pain relief with drugs 
such as nitric oxide, chloroform and opioids in particular morphine. The idea of pain free 
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labour bore two perspectives: one was that if “God” intended labour to be pain free it 
would have been and that the complications including poor fetal outcomes were due to 
painless labour. The second perspective was that pain relief was necessary and 
welcomed.2  
Over the years it became imperative that adequate analgesia be available to women in 
labour, and has been endorsed by the American College of Obstetricians and 
Gynecologist (ACOG), who stated  "Labour results in severe pain for many women. There 
is no other circumstance where it is considered acceptable for a person to experience 
severe pain, amenable to safe intervention, while under a physician's care".3  
In the 19th century the first neuraxial analgesic, was introduced into obstetric practice, in 
which a Swiss obstetrician injected 0,01g of cocaine into the subarachnoid space. The 
major complication reported was post-dural headaches.4 
In 1931, the caudal epidural was used in which a needle was introduced at the caudal 
level and a catheter left within the space to allow for repeated injections as labour 
progressed. In early 1960, lumbar epidurals replaced caudal epidurals, as lumbar 
epidurals provided more comfort for the women and was easier to perform. Lumbar 
epidurals required less analgesia, maintained lower limb and abdominal muscle motor 
function and decreased the effect on the sympathetic nervous system with less 
hypotension.4 
1.2 Physiology of pain in labour  
During the first stage of labour, the pain experienced is related to regular uterine 
contractions as well as dilatation of the cervix, and is best described as cramping and 
visceral in nature. Pain perception arises in mechanoreceptors that are stimulated due to 
intense pressure generated by contractions and activation of chemoreceptors, due to 
myocellular injury, release of bradykinins, histamine, serotonin and acetylcholine in the 
uterus and cervix. Sensations from A delta and C afferent pain fibers collectively join 
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along the right and left cervical plexus, from here they are transmitted to the hypo gastric 
plexuses where pain transmission is then carried towards the spinal cord in the lumbar 
paravertebral sympathetic chain. Nociceptors enter the spinal cord via the dorsal nerve 
roots of T10-L1 and travel to the thalamus, brainstem and cerebellum via the 
spinothalamic tract. A final synapsis occurs within the thalamus before projections to the 
sensory cortex, where painful stimuli are perceived.5 
The pain experienced during the second stage originates from the distention and 
stretching of the perineum and pelvic floor, and is somatic in nature and better localized.6 
Transmission of pain is then sent via the pudendal nerve, which originates from the 
second to the fourth sacral nerve.5 The hallmark of this stage is Ferguson’s reflex, which 
results in intense uterine contraction and further activation of pain pathways.5  
1.2.1 Consequences of painful labour on the mother 
Painful labour is associated with activation of the sympathetic nervous system and 
increase in the plasma concentrations of epinephrine, which activates the beta-adrenergic 
systems that can offer tocolytic properties. The elevated levels of cathecholamines in 
particular that of epinephrine especially during painful labour, leads to an increase in 
cardiac output and total peripheral resistance, which in turns leads to decreased placental 
blood flow, which may compromise fetal well being.6,7  
While this may be well tolerated by healthy women and their babies, the sympathetic 
overdrive seen with strong uterine contractions may exacerbate pre existing cardiac 
and/or haemodynamic compromise. These autonomic changes also result in deteriorating 
metabolic acidosis, which can be transmitted to the fetus resulting in poor Apgar scores at 
birth.6  
A painful labour experience can have a negative impact on a female, leading to fear of 
pain in the next pregnancy, increased requests for caesarean sections and even 
emotional withdrawal from sexual partners. Painful labour leads to uterine dystocia and 
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uncooperative women particularly during the second stage of labour, resulting in 
prolonged labour, traumatic deliveries and increased incidence of caesarean delivery.6,7  
1.2.2 Effect of painful labour on the fetus 
It has been shown that severe maternal pain and anxiety during latent phase of labour 
correlates with fetal CTG changes during the active phase of labour and resultant lower 
Apgar scores.  Painful uncoordinated labour leads to increased levels of norepinephrine 
and epinephrine. This results in vasoconstriction of the uterine arteries and uteroplacental 
insufficiency may occur.8  
The effects of painful, uncoordinated contractions may lead to a further decline in 
placental perfusion and a state of hypoxemia within the fetus, metabolic acidosis and CTG 
changes such as decreased variability, recurrent late and variable decelerations and 
bradycardia.9   These CTG changes result in an increased need for expedited delivery, via 
caesarean section or if favorable assisted vaginal delivery. Therefore painful labour is 
associated with increased rates of caesarean section and assisted vaginal deliveries, 
together with their associated fetal complications.10 
1.3 Analgesia used in labour  
Currently there are multiple options available for analgesia in labour and these include 
pharmacological and non-pharmacological methods, which may be regional or non 
regional. Non-pharmacological methods, are non invasive with a good safety profile for 
women and babies but there is limited data on their efficacy. Pharmacological methods 
despite their risk of adverse effects are used as the primary method of pain relief. Non-
pharmacological methods can be combined with pharmacological interventions to 
increase their effectiveness. Ultimately analgesia should be tailored to the needs and 
circumstances of the women in labour.11 
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1.3.1 Non-pharmacological analgesia used intrapartum 
Non-pharmacological analgesia while not commonly used, has the advantage of minimal 
side effects. Many of the non-pharmacological techniques are inadequately studied due to 
a small population size therefore making it difficult to comment on its efficacy as a labour 
analgesic. These methods include transcutaneous electrical nerve stimulation (TENS), 
relaxation/breathing techniques, temperature modulation with hot or cold packs, water 
immersion, hypnosis, massage, acupuncture and aromatherapy.9 
1.3.2 Pharmacological analgesia used intrapartum 
 
1.3.2.1 Non Regional analgesia used intrapartum   
Nitrous Oxide 
Nitrous oxide, which consists of 50% nitric oxide in oxygen, is an inhalational agent, that 
increases release of endorphin, dopamine and other natural pain relievers in the brain. It 
does not completely relieve the pain of labour but instead creates “diminished pain”, 
through its anti-anxiety effect. Its onset of action is within 20-30 seconds and maximal 
effect at 45 seconds. The advantage lies in the ease of use, safety profile for both women 
and their new born, with no need for physician supervision and can be used in resource 
poor areas where other analgesia is not readily available. Its also provides women with 
control over their own pain management.12 
The side effects include drowsiness, disorientation and nausea with a minimal incidence 
of loss of consciousness. While nitrous oxide may provide pain relief in labour, it is not 
comparable to that of systemic opioids, in that systemic opioids showed a reduction of 
pain by 1,5 points on a visual analogue scale versus a 0,5 reduction with nitrous oxide.6   
Nitrous oxide is not available for use at CHBAH. 
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Systemic Analgesia  
Pethidine is the most commonly used systemic analgesic during the labour process. 
Studies conducted on the efficacy of pethidine as an adequate analgesic intrapartum 
reports that it offered slightly better relief that the placebo but the adverse effects to 
mother and fetus outweighs the minimal reduction in pain.13 
Rather than effective analgesia, its primary mechanism of action is heavy sedation and 
labour pain is not sensitive to systemic administration of pethidine or morphine.  
Pethidine’s side effect profile includes delayed gastric emptying, sedation, dose 
dependent respiratory depression and its active metabolite may result in convulsions.12, 13 
Pethidine readily crosses the placenta and is detectable in the fetus within a minute 
achieving equilibrium with maternal plasma levels within 6 minutes.14 
The effects of pethidine on the baby which include respiratory depression, poor suckling, 
slower establishment of breastfeeding, thermoregulation impairment and Apgar scores of 
<7 at birth, may be attributed to the presence of it’s long acting metabolite norpethidine 
(half life 60 hours).14 
Other systemic analgesia available but not used in our setting is that of morphine, 
diamorphine and fentanyl.  
1.3.2.2 Regional Analgesia 
Regional analgesia, which includes epidural analgesia, together with its modified delivery 
systems such as patient-controlled epidural analgesia and combined spinal epidural 
technique, is the preferred method of analgesia intrapartum. In particular epidurals 
provides improved labour analgesia with better maternal and fetal outcomes in 
comparison to older methods such as inhaled nitrous oxide, parental opioids and non-
pharmacological methods.15 While evidence exists on the benefits of epidural analgesia 
use intrapartum, the incidences of its use in developing countries are relatively low in 
comparison to developed countries 7.5% vs. 50%.1,15  The decreased use of epidural as a 
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labour analgesia is based on reservations from medical staff and women in labour, based 
on the ideas that epidural analgesia prolongs labour and increases the risk of caesarean 
and assisted vaginal delivery.16,17,18 Epidural analgesia has been shown to be associated 
with an increased duration of second stage of labour by 15,55 minutes (95%CI 7.46 to 
23.63 minutes) and an increased incidence of operative vaginal delivery, RR 1.3 (CI 
95%).1 
1.4 Epidural Analgesia   
 
1.4.1 What is an Epidural? 
Epidural anaesthesia is a form of regional anaesthesia commonly referred to as neuraxial 
blocks, produced by injection of a local anaesthetic agent into the lumbar area of the 
spine in the epidural space (between the spinal cord and the dura). The injection may 
provide both motor and sensory loss by blockage of pain signals in and around the site of 
insertion.  
1.4.2 Anatomy of the Epidural Space  
The epidural space begins cephalad at the foramen magnum and extends caudally to the 
sacrococcygeal membrane. It is bound anteriorly by the posterior longitudinal ligament, 
posteriorly by the anterolateral surface of the vertebral lamina and the ligamentum flavum 
and laterally by the pedicles of the vertebrae and the intervertebral foramen. 
1.4.3 Contraindications to Epidural use 
Absolute contraindications to the use of epidural anesthesia include uncorrected 
hypovolemia as this could lead to severe maternal compromise due to the sudden decline 
in blood pressure within the first 120 minutes of epidural insertion, raised intracranial 
pressure, infection at site of insertion, patient refusal and allergies to any of the drugs 
used.19 
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Relative contraindications to the use of epidural anesthesia include coagulopathy, fixed 
output states, active maternal hemorrhage, uncooperative patient, spinal abnormalities, 
sepsis and positioning problems.19  
1.5 Epidural analgesia in obstetrics practice  
Epidural analgesia offers the most effective, reliable method of analgesia during the 
labour process. Besides the marked pain relief, other advantages include the ability to 
provide surgical anesthesia, for instrumental or operative delivery and laceration repair.19   
The rate of regional analgesia, particularly that of epidural use has increased substantially 
over the past 5 years with more than 50% of women receiving intrapartum analgesia in 
most developed countries. The wide spread use was contributed to factors like improved 
maternal and fetal safety profiles associated with epidural use.20  
Epidural analgesia blocks the maternal stress response, thereby allowing the women to 
be in control of her labour and reverses the unwanted physiological consequences of 
painful labour.1,19,20  Advantages to intrapartum epidural use is classed with the relative 
risk of prolonged labour, caesarean and assisted delivery and use of oxytocin for 
augmentation of labour. 
1.5.1 Benefits of intrapartum epidural analgesia 
Epidural intrapartum analgesia was compared to non-epidural intrapartum analgesia and 
no analgesia. Epidural analgesia was shown to provide better pain relief with a weighted 
mean difference of 2.60 (95% CI -3.82 to -1.35) using the visual analogue scale.1 
The adequate pain relief associated with epidural analgesia decreases the metabolic 
acidosis often associated with painful labour. This in turn results in improved neonatal 
outcomes, improved Apgar scores and a reduction in neonatal admissions. This then 
allows for early bonding between mother and child and initiation of breast-feeding. Unlike 
other methods of analgesia such as nitrous oxide and pethidine, epidural analgesia does 
not cause drowsiness and therefore facilitates cooperation by the woman during the 
	 9	
labour process. A Cochrane review, that evaluated the neonatal outcomes of women that 
received epidural analgesia compared to non-epidural use, reported a lower risk of 
umbilical pH below 7.2 within the epidural group.1,21  Moreover, epidural analgesia 
provides pain relief for assisted vaginal delivery and episiotomies.1,14 
Epidural analgesia provides sufficient pain relief to eliminate the need for systematic 
opioid use and the side effects associated with its use, and even after 15 hours of epidural 
exposure the Apgar score and time to sustained respiration remained unaffected in 
healthy neonates.14 
Epidural analgesia is beneficial in women that have co morbidities particularly that of 
preeclampsia and cardiac disease, as it results in peripheral vasodilation, decreased 
venous return and decreases maternal blood pressure.22,23 A study that looked at the 
effect of epidural analgesia on the Doppler velocimeter of the umbilical and uterine arties 
in normal and preeclamptic women recorded an improvement in umbilical flow post 
epidural analgesia. Epidural analgesia therefore provides both maternal and fetal benefit, 
through improved uteroplacental blood flow and decreased in maternal mean arterial 
pressure.24,25 This would be beneficial in obstetrics, considering that preeclampsia 
complicates 2-3% of all pregnancies globally and Frank, et al. reported a 5.8% incidence 
of proteinuric hypertension in pregnancies in a Sowetan population.26   Women with 
cardiac pathology other than fixed cardiac output states e.g. mitral stenosis would benefit, 
in that epidurals due to its effective analgesic properties decrease the release of 
catecholamine and in turn decrease the cardiac output. The increase in cardiac output, 
which is seen with intense pain, can be fatal to a heart that is already compromised.23 
Additionally, if at any point during the labour process a woman requires a caesarean 
section the epidural can always be supplemented to provide surgical anaesthesia and 
prevent the likelihood of general anaesthesia. 
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1.5.2 Maternal complications associated with epidural use  
The use of regional analgesia, particularly epidural analgesia has increased over the past 
10 years within developed countries, due to its safety profile and low risk of long-term 
severe complications. In an audit conducted in France the incidence of severe 
complications was 5 in 10000, comparable to Scott, et al. who reported a 1 in 1000 
risk.27,28 
1.5.2.1 Accidental dural puncture  
Postdural puncture headache (PDPH) is the most common complication of epidural 
analgesia with an incidence of 0-30%.29 It commonly occurs within 7 days of the epidurals 
insertion and resolves within 14 days and is typically postural in nature, resulting from 
leakage of cerebrospinal fluid and a decrease in intracranial pressure with a 
compensatory cerebral vasodilation.18,30 
 Postdural puncture headaches, while usually self-limiting should be treated 
conservatively for 24 hrs. If no resolution occurs within 24 hours, active management 
should be instituted, as it may be associated with severe mortality.20 The definitive 
treatment for persistent postdural puncture headache is an autologous epidural blood 
patch (i.e., sterile injection of 15 to 20 mL of the patient's fresh blood into the epidural 
space, preferably at the site of the dural puncture).18,29,30 
1.5.2.2 Hypotension 
The incidence of maternal hypotension is 10%, and is similar for both epidural analgesia 
and combined spinal- epidural analgesia.19,31 Maternal hypotension occurs as a result of a 
decrease in the sympathetic chain afferent outputs leading to vasodilation and a sudden 
reduction in both systolic and diastolic blood pressure, usually occurring during the onset 
of epidural analgesia. This complication is tolerated in women and their fetus without any 
pre existing compromise, particularly placental insufficiency. The placenta lacks the ability 
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to autoregulate and any decline in maternal blood pressure particularly MAP below 65 
mmHg can result in a decline in placental blood flow and CTG changes.17 
Controversy exists on weather or not to preload women with a crystalloid solution prior to 
epidural placement. A study conducted on 95 normotensive women, assigned to receive 
1000 ml of crystalloid fluid pre epidural versus no fluid, reported no benefit. The frequency 
of hypotension was 6% versus 10% in the control group.32 Dyer R, et al. and Hofmyer G, 
et al. reported similar findings.32,33,34 Dyer R, et al. further concluded that preloading 
women with crystalloid solution may induce atrial natriuretic peptide secretion, leading to 
vasodilation and hypotension.33 Women should rather be monitored closely and measures 
instituted early with the use of epinephrine as hypotension can result in decreased utero 
placental blood flow and an 8% incidence of transient fetal heart rate deceleration.35 This 
is of clinical significance as most clinicians view the change in fetal heart rate negatively 
and tend to book women for caesarean section deliveries.  
1.5.2.3 Pyrexia  
Women in labour who receive epidural analgesia are more likely to experience pyrexia 
with an overall 3 times greater risk compared to non epidural use (RR 3.34, 95% CI 2.63-
4.23).1  There is an incidence of 24% in nulliparous women versus 8% in multiparous 
women.  Initially its was thought that all women who receive epidural analgesia 
intrapartum have an increase in core body temperature, but the current consensus is a 
20% incidence of pyrexia. An overall increased incidence of pyrexia appears by four hours 
of exposure and increases with increasing duration.35 The major consequence of this is an 
increase in metabolic rate, cardiac output and oxygen demand, which could be benign to 
the healthy woman but complicate management of women with cardiac or pulmonary 
diseases.35,36    
1.5.2.4 Failed epidural analgesia 
Failed epidural analgesia or inadequate pain relief is a complication, seen more often in 
the obstetric woman when compared with surgical women. Failure rates, range from 
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13,5% - 24% in intrapartum obstetric women compared to 4% in surgical women.20,37 
Epidural failure is multi-factorial and some common causes include; increased Body mass 
index (BMI), which is related to difficulty in placement and technique, fetal positioning and 
analgesic effect of the initial dose. In terms of the fetal position, a posterior lie is 
associated with an increased labour duration, uncoordinated uterine contractions and 
increased hormonal release all of which increases the intensity of uterine contraction 
beyond the analgesic effects of epidural analgesia.37 
1.5.2.6 Other Complications  
Other less common complication includes infection at site of placement, including 
meningitis, spinal analgesia, high spinal, death and paralysis. The incidence of transient 
or permanent neurological complications is reported to be between 1/1000 to 1/1000000. 
Epidural hematoma occurs in 1/15000 healthy women and is more commonly seen in 
women with haemostatic abnormalities. Cardiac arrest has been reported in 1/10000. 27 
1.5.3 Labour associated complications  
Epidural analgesia is often associated with increased rates of caesarean section 
deliveries for uterine dystocia. The cause of the increased rate is still unclear and may be 
due to the effects of epidural anaesthesia on motor blockage with decreased perception of 
uterine contraction or failure of descent of the fetal head. The motor blockade, associated 
with epidural use may result in relaxation of the pelvic floor muscles, which may alter the 
descent and rotation of the fetal head, leading to labour dystocia.  Several retrospective 
studies based on epidural analgesia and their effect on labour showed a consistent 
increase in the duration of the first and second stage of labour, use of oxytocin, assisted 
vaginal and caesarean deliveries.38,39  Other studies refute such conclusions on the basis 
that women who request epidural analgesia, may already have features of poor progress 
and/or dystocia secondary to pain, and therefore the event of caesarean delivery may be 
due to the pain rather than the initiation of epidural analgesia.40,41,42 
Anim-Somuah M, et al. who performed a systemic review of all trials that assessed the 
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effect of epidural analgesia on the relative risk of caesarean section, which included a 
total of 6534 women, reported no evidence of a significant difference in the risk of 
caesarean delivery (RR 1.07, 95% CI 0.93 to 1.23, 20 trials) with epidural use versus non 
epidural use.1 Gribble R, et al. studied the effect of an “on demand epidural service” and 
the effect on the caesarean section rate. He found no difference in the caesarean section 
rate before the epidural service compared to after its introduction. 43 
Thorp J, et al. reported an increased frequency of caesarean delivery among nulliparous 
women who received epidural analgesia compared to those that received narcotic 
analgesia 2.2% versus 25%, p < 0.05. 38 
Ramin S, et al. completed a randomized control trial that looked at the effect of epidural 
analgesia with intravenous pethidine on the effects of labour and found a two fold 
increased risk of caesarean section deliveries with the use of epidural analgesia.39 
Dickson J, et al. conducted a trial on factors influencing the selection of analgesia in 
spontaneous labouring nulliparous women at term. In this study they randomized 
nulliparous women to either the epidural or non-epidural analgesia group during their 
antenatal visits. They reported a cross over rate of 61.3% from the non-epidural group to 
the epidural group, with the painful labour being the main reason for cross over. He further 
concluded that epidural analgesia and choice thereof is not a random event and more an 
indicator of abnormal labouring patterns.40 The findings are similar to a study conducted 
by Halpern S, et al. that suggested that nulliparous women are more likely to request 
epidural analgesia due to the increased risk of labour dystocia.41 
A recent UK based trial, COMET assessed the effects of different epidural regimes on the 
mode of delivery. The study randomly assigned 1054 nulliparous women to the traditional 
epidural regimen (intermittent 10 mL boluses of 0.25% bupivacaine), low-dose combined 
spinal–epidural regimen (CSE) (bupivacaine 2.5 mg and fentanyl 25 mcg, followed by a 
15 mL bolus of 0.1% bupivacaine and 2 mcg/mL fentanyl when the spinal component 
wears off with intermittent 10 mL boluses of this combination of drugs), or low-dose 
infusion epidural regimen (bolus of 15 mL 0.1% bupivacaine and 2 mcg/mL fentanyl 
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followed by an infusion of 10 mL/hour of same). They reported a higher rate of 
spontaneous vaginal deliveries within the low dose infusion epidural group compared to 
the traditional group (43% vs. 34%). They also reported a decrease in caesarean section 
and operative deliveries. This suggests that traditional higher dose epidural regimes could 
have been responsible for the relative increased risk of caesarean sections and operative 
deliveries, reported in the past.42 
Zhang J, et al. evaluated the rate of caesarean section, instrumental deliveries and 
prolonged labour with the introduction of epidural analgesia. He reported that despite the 
rapid increase in epidural usage (1%-85%, over 1 year) the rates of caesarean section 
deliveries remained the same. He also reported no increased incidence of instrumental 
deliveries (adjusted relative risk, 1.0; 95% confidence interval, 0.8-1.4), no increase in 
duration of the first stage of labour, but noted an increase in the duration of the second 
stage of labour by 25 minutes.44 
Ramin, et al. concluded that the relative risk of a prolonged second stage of labour with 
epidural use was 9.6 CI 95%.39  Similar findings were reported by Zhang J, et al.44 ,Anim-
Somuah M, et al1 and the COMET trial.42 Each concluded an average increase in duration 
of 15 minute, with Zhang J concluding the average duration being higher in nulliparous 
women compared to multiparous women, 70 minutes vs. 35 minutes respectively.1,38,40,41,42 
American Congress of Obstetrics and Gynecology Committee Opinion who previously 
published that “epidural does increase the incidence of caesarean deliveries” has after 
recent meta analyses concluded that epidural analgesia does not increase the rates of 
caesarean deliveries (odds ratio 1.00–1.04; 95% confidence interval, 0.71–1.48). 45 
Another associated risk of epidural analgesia is the increased incidence of oxytocin use, 
Timothy J, et al.  a medical endocrinologist looked at the effect of epidural analgesia on 
serum concentration of cortisol, beta-endorphins, plasma glucose and lactate and mean 
plasma oxytocin concentration 10 minutes post epidural and throughout labour. 7 Although 
the study population only consisted of 9 women it demonstrated a decrease in stress 
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biomarkers, with no change in glucose, lactate or serum oxytocin levels throughout labour, 
suggesting that if epidural does interfere with progress of labour the mechanism is not 
through a decrease in oxytocin secretion.7 A study conducted on the effects of epidural 
analgesia on the second stage of labour found that, women who receive intrapartum 
epidural are 3,5 times more likely to receive oxytocin for augmentation of labour in 
comparison to women who receive other forms of analgesia. Within this study however, of 
the 101 women who requested epidural analgesia for pain management, 69 (68.3%) 
women received oxytocin for augmentation of labour prior to epidural placement with only 
20(19.8%) women receiving oxytocin after epidural analgesia, therefore suggesting the 
presence of painful dysfunctional labour prior to epidural request, suggesting once again 
an associative rather than a causal relationship.46 A similar study conducted by Lewis L, et 
al. studied which came first, the oxytocin or epidural analgesia and found that 62% of 
women who received epidural analgesia, had an oxytocin infusion started prior to the 
placement of the epidural catheter. The study also showed that 21% of women received 
oxytocin after the placement of the epidural catheter. 47 
Much debate still exists on the use of epidural analgesia as a form of intrapartum 
analgesia and its effects on the labour process.  
1.5.4 Fetal complications   
Epidural analgesia can have a direct and indirect effect on the fetus. The direct effect is 
due to systematic absorption of opioids. Epidural analgesia however does not depend on 
maternal systematic absorption for its mechanism of action. Therefore the likelihood of 
direct fetal effects is rare.  The indirects effects are a result of the alteration in maternal 
physiological and biological changes. 48 Due to the rapid onset of pain relief seen with 
epidural analgesia intrapartum there is a decline in maternal stress response and a 
resultant imbalance in norepinephrine and epinephrine levels. This imbalance leads to a 
loss in the relaxant effects on the uterus produced by epinephrine leading to uterine 
hypertonicity and fetal heart rate abnormalities. 48,49 
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 Raynold F, stated that “instead of examining the effect of any procedure on the newborn, 
various surrogate outcomes such as maternal blood pressure, fetal heart rate, duration of 
labour, need for oxytocin, delivery type and even maternal fever are assumed to equate 
with fetal/neonatal welfare”.48 This is particularly true for epidural analgesia, as most 
health professional and women are more concerned of its effect on labour and transient 
risk of CTG changes as opposed to it beneficial effect for the neonate.  
Epidural analgesia is associated with an 8% transient risk of CTG changes post-epidural 
placement. 32 A meta-analysis of nine trials reported a transient risk of fetal bradycardia 
within one hour of epidural administration in 7.3 % of women in comparison to 4.8% of 
women in whom epidural analgesia was not used, [RR] 1.81, 95% C.49 
The proposed theory on fetal heart rate changes is that epidural analgesia, through its 
rapid onset of action results in uterine hyperstimulation. This theory is supported by a 
study done that looked at the incidence of elevation in uterine basal tone in women that 
received combined spinal epidural (CSE) compared to traditional epidural analgesia and 
its effect on the fetal heart rate patterns. Sixty four percent of women had changes in fetal 
heart rate patterns in the CSE group compared to 16% in the traditional group.50   
A meta analysis of controlled trials on systemic opioids versus epidural analgesia showed 
no difference in incidence of fetal heart rate changes between the two groups. It did 
however report better neonatal outcomes in the women who received epidural analgesia 
as opposed to systemic opioids. 51 
Maternal hypotension secondary to epidural analgesia has been shown to result in fetal 
heart rate abnormalities. The placenta lacks the ability to auto regulate and is dependent 
on maternal blood pressure for perfusion. Any decline in maternal blood pressure can lead 
to decreased fetal oxygenation and CTG changes.51 Some studies have postulated that 
preloading women with intravenous fluid has been shown to decrease the incidence of 
fetal heart rate abnormalities following epidural analgesia (p=0.025, OR 0,03 95% 
CI).32,33,34  
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Epidural analgesia is associated with improved neonatal outcomes, better Apgar scores 
and lower risk of having an umbilical pH <7.2 (RR0.80 95%CI 0.66-0.96) when compared 
to systemic opioids. 1,21,51 There is also a reduction in need for naloxone and admission 
into neonatal ICU. Schockets M, et al. looked at the neonatal outcomes and umbilical 
artery pH post delivery of 110 babies whose mothers had epidural analgesia compared to 
women who had no analgesia. He reported similar pH values between the two groups, but 
significantly higher paCO2 within the epidural group, suggesting a reduction in maternal 
hyperventilation and fetal metabolic acidosis.52 Therefore epidural analgesia is associated 
with improved neonatal outcomes when compared to non epidural analgesia and no 
analgesia. Early studies reported that neonates born to women who received epidural 
analgesia had lower neonatal neurobehavioral scores.21 Longitudinal studies showed no 
difference in scores between neonates born to women who had received epidural 
compared to those that received no analgesia or non epidural analgesia.1,21  
 
2.0 PROBLEM STATEMENT 
Epidural analgesia is the most effective means of labour relief; limiting access to such 
service based on the assumption that it increases suboptimal outcomes in obstetric would 
force many women to endure severe labour pain.45 
The provision of an epidural service is limited by anaesthetic staff availability and 
therefore accessible to a select few. The quality and outcomes of the epidural services at 
CHBAH has never been evaluated and hence the need for this study. This institution has 
the largest number of deliveries in South Africa, on average performing 17000 deliveries 
per annum with an epidural services operating Monday to Friday, 8 am to 16pm. This 
would be the ideal place to evaluate outcomes of such a service.The results will facilitate 
positive reinforcements in offering such services with information on likely outcomes for 
women, midwives and doctors, and facilitate the development of guidelines for the 
management of women receiving epidural analgesia intrapartum.  
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2.1 Objectives of the study 
 
To describe the: 
1. Maternal outcomes and complications in women receiving intrapartum epidural 
analgesia.  
2. Neonatal outcomes of babies born to women who receive labour epidural analgesia. 
To assess the: 
1. Progress of labour in women receiving intrapartum epidural analgesia. 
2. Incidence of caesarean section and instrumental deliveries in women receiving 
intrapartum epidural analgesia. 
 
3.0 MATERIALS AND METHODS 
 
3.1 Setting 
This study was conducted in the Maternity Unit at CHBAH, a tertiary care institution 
situated in Soweto, and provider of medical care to a population of 1,3 million people and 
is the referral center for primary and secondary health care facilities, as far as Klerksdorp 
within the North West Province.  
The Department of Obstetrics and Gynaecology, has 21 beds for women in active phase 
of labour, 16 latent phase beds, 7 high care beds and an admission ward. On average 
there are about 420 deliveries, performed each week. These include both normal vaginal 
deliveries and caesarean sections, with an average caesarean section rate of 40% weekly. 
The department has two operating theatres that function over a 24-hour period, 7 days a 
week. 
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 The average turnover time in labour ward is 15 – 20 hours. Clinical assessment of 
women occurs hourly by sisters and 2 hourly by doctors.  Due to the large number of 
women at CHBAH and the limited resources available many women do wait on average 2 
hours before adequate management can be established, especially in respect to 
caesarean section deliveries. The standard waiting time for caesarean section differs 
depending on the triage system, in that emergencies of maternal or fetal nature e.g. 
antepartum haemhorrage and fetal distress usually taking precedence and set at 1 hour, 
where semi urgent caesarean sections e.g. poor progress with no fetal compromise 
averaging 3,5 hours. Women who present in labour with features suggestive of poor 
progress or prolonged latent phase of labour and who have not had a previous caesarean 
section are managed initially with oxytocin. The oxytocin regimen used at CHBAH is, 2 
units of oxytocin in 200 ml normal saline at a rate of 12 ml/hr, increasing to 24 ml/hr, 36 
ml/hr and 48 ml/hr every 30 minutes up until the establishment of adequate contractions. 
The maximum dose is 72 ml/hr.  
An epidural service at CHBAH offers analgesia to women intrapartum particularly during 
the active phase of labour. The service is available Monday to Friday 8h00 to 16h00, with 
a dedicated anaesthesiologist at any given time. On average the expected number of 
epidurals per week is 15 or 3 per day. The anaesthesiologist offers the service to women 
that are in active phase of labour, and obtains informed consent prior to the procedure. 
The informed consent details the procedure, the benefits of epidural analgesia in term of 
labour, alternative analgesia available and the risk associated with such a procedure. 
Once the woman is agreeable to the epidural service, she signs the consent and is 
prepared for epidural placement. The epidural protocol is as follows: 
• The epidural trolley is checked daily.  
•  Women that would benefit from epidural analgesia are Identified. Ideal candidates 
would be women in the active phase of labour, with no contraindications to epidural 
analgesia.
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• Before an epidural is performed consent is obtained from the women. Baseline vitals 
such as BP, heart rate and temperature is obtained. The women’s intravenous line is 
checked and a urinary catheter is inserted.  
• The epidural pack is opened in an aseptic manner, together with the following items: 
o epidural set 
o needles/syringes for local anaesthetic infiltration to skin and for a test dose 
o drug ampoules: 
• 2 x 2% lignocaine 
• 1 x 200ml 0.9% sodium chloride 
• 1 x fentanyl 100ug 
• 1 x 10ml 0.5% bupivacaine  
• An epidural mix consisting of 10ml 0.5 ml bupivacaine, 2 ml fentanyl(100ug) and 38 
ml 0.9% sodium chloride is drawn up. 
• The women is placed in a seated position and landmarks are identified. Local 
anaesthetic is given subcutaneously.  
• The epidural catheter is inserted. After placement of the epidural, a test dose is given 
and if no motor block occurs the first bolus of 5 ml of epidural mix is given. 
• After the initial bolus of drug and after each top-up bolus, the BP, pulse, oxygen 
saturation, level of consciousness, presence of a motor block and fetal heart rate is 
recorded every 5 minutes for the next 30min, thereafter, half-hourly. 
• If abnormality is noted such as a systolic BP < 100mmHg,  HR< 60 or > 110bpm, 
SPO2 < 92%, decreased level of consciousness or presence of a motor block, the 
following is done: 
o Commencement of a Vasopressors and wait for response 
o Exclude aortocaval syndrome 
o Commence resus if needed 
o Give supplemental oxygen 
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o Check patient observations  
The labour ward is fully equipped with resuscitation equipment and theatre facilities within 
the vicinity for potential complications.  
3.2 Study Design 
This was a retrospective cross sectional descriptive study of all women who received 
intrapartum epidural analgesia and the neonates born thereof between 01/05/2015 and 
31/10/2015. 
3.3 Study population 
The study population comprised all women who received epidural analgesia intrapartum 
and the neonates born to these women at CHBAH.  
3.4 Inclusion Criteria 
All women who received epidural analgesia for labour during the study period, including 
the neonates born to these women. 
3.5 Exclusion Criteria 
Any women that had incomplete records or no records.  
3.6 Definitions 
For the purpose of this study the following definitions were used: 
Antenatally booked:  at least one antenatal clinic visit with risk factor assessment and 
the testing of maternal blood for Rhesus status, rapid plasma reagin test, HIV and 
haemoglobin levels. 
Latent Phase of labour: presence of labour and the cervix is <4 cm dilated and ≥1 cm 
long. 53 
Active Phase of labour: begins at 4 cm of cervical dilation and is characterized by rapid 
cervical dilation and descent of the presenting fetal part. 53 
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Neonatal birth Trauma: Injuries to the infant that result from mechanical forces during 
the birth process. 
Poor Progress: a cervical dilatation rate of less than 1 cm/hr in the active phase of labour 
in the nulliparous women, and a dilation rate of less than 1,5 cm/hr in the multiparous 
women, and/or the partogram crosses the alert line. 53 
Prolonged Second stage of labour: no descend of the fetal head onto the pelvic floor 
after 2 hours of full dilatation, and/or delivery has not occurred after 45 minutes of pushing 
in a nulliparous women, or 30 minutes of pushing in a multiparous women. 53 
Instrumental deliveries: a delivery in which an operator uses either forceps or a vacuum 
device to extract the fetus from the vagina. Also referred to as operative or assisted 
vaginal deliveries. 
Spinal analgesia: Anaesthesia produced by injection of a local anaesthetic solution into 
the spinal subarachnoid space, resulting in both motor and sensory blockage 
Low Apgar score: Apgar score of less than seven at birth. 
Fetal distress: compromise of the fetus during the antepartum or intrapartum period 
assessed by means of an NST in keeping with NICE guidelines, in terms of a pathological 
trace.  
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Table 1 CTG tracing as per modified ACOG and FIGO: 
Parameter Baseline rate 
(bpm) 
Variability 
(bpm) 
Decelerations Accelerations 
Reactive 110-160 >5  none present  
Suspicious <110 or >160 <5 or >25 for 
>40 minutes 
early/variable 
decelerations 
prolonged 
decelerations > 
3 minutes  
present 
Pathological <100 or >180 
Sinusoidal 
pattern 
<5 for >90 
minutes 
Atypical variable 
late 
decelerations or 
prolonged 
decelerations >3 
minutes 
absent > 40 
minutes 
 
Fetal outcomes will be subdivided: 
No adverse fetal outcome:  relates to a live well baby at discharge with no need for 
admission immediately post delivery. 
Adverse fetal outcome: constitutes one of the following: Apgar score < 7, demise within 
28 days, fresh stillbirth, intrauterine fetal death, cephalohaematoma or hypoxia ischemic 
encephalopathy.   
Combined adverse fetal outcomes:  cephalohaematoma and demise within 28 days, 
low Apgar scores and hypoxic ischemic encephalopathy, Apgar score < 7 and demise 
within 28 days.  
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Preeclampsia: diastolic blood pressure of 90 mmHg or more, on 2 occasions at least 4 
hours apart or a single diastolic blood pressure reading of 110 mmHg, with ≥1+ 
proteinuria on a urine dipstick. 58 
Mean Arterial Pressure: the average arterial pressure during a single cardiac cycle, 
calculated as MAP = [(2 x diastolic) + systolic] divided by 3. 
Baseline Mean Arterial Pressure: mean arterial pressure taken just prior to placement of 
epidural catheter. 
Change in Mean Arterial Pressure:  any change in mean arterial pressure from the 
baseline not equal or greater than 10% decrease from baseline, or meeting the definition 
of hypotension.  
Hypotension: blood pressure lower than 90/60 mmHg, or a MAP<60 mmHg with or 
without the presence of symptoms. 
Pyrexia: body temperature greater than 38.30C as per the World Health Organization. 
Failed Epidural: Epidural or CSE procedures resulting in inadequate analgesia or no 
sensory block after adequate dosing at any time after initial placement, inadvertent dural 
puncture with the epidural needle or catheter, or any technique requiring replacement or 
alternative management 59 
3.7 Data collection 
Women that received epidural analgesia intrapartum were identified from the epidural 
registers at the CHBAH. The medical records of these women were retrieved and the 
relevant data reviewed, captured and analyzed. If the medical records were not obtained, 
detailed of the delivery and outcomes were found within the maternity registers held at the 
hospital. Details of the neonatal outcomes of these women were sought from the maternal 
records and the neonatal registry. In order to maintain anonymity each women received a 
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study number.  The data sheet only reflects the study number and data pertaining to the 
study. 
3.8 Variables recorded 
The following variables were recorded: 
Maternal  
Age, parity, gravidity, booked/unbooked, gestational age, maternal weight, 
maternal illnesses, booking bloods, race  
Epidural Analgesia 
Observations: blood pressure, heart rate, temperature, respiratory rate; before and 
after epidural placement, intra epidural significant event, difficulty with placement 
of epidural, level of epidural analgesia, density of block, complications associated 
with epidural analgesia. 
Labour  
Total duration of labour, rate of cervical dilation, use of oxytocin, duration of 
oxytocin before and after epidural placement, duration of second stage of labour. 
Delivery 
Mode of delivery, indications for caesarean section, instrumental deliveries, 
presence of postpartum hemorrhage, blood transfusion, hysterectomy, high care 
or ICU admission, other complications. 
Neonatal outcomes  
 Birth weights, corticosteroid requirements, fetal heart rate monitoring before and 
after epidural placement, 1 minute Apgar scores, neonatal admission to NICU, 
birth trauma, significant morbidity and perinatal mortality. 
	 26	
A detailed list of variables recorded is reflected on an attached copy of the data sheet 
(Appendix A). 
3.9 Data Analysis 
Data was analysed using Epi Info v3.5.1 software, with the aid of a statistician. Descriptive 
statistics were employed, means with standard deviations and medians with ranges. 
Frequencies were expressed in percentages. For variables less than 5, Fischer exact test 
was used to calculate p-values and for the remaining data greater than 5 an Annova test 
was used. A p-value of <0.05 was used to determine statistical significance. 
3.10 Ethical Considerations 
The study was only commenced after the Postgraduate Committee and Human Research 
Ethics Committee (Medical) of the University of the Witwatersrand gave approval. 
(Appendix B). Clearance certificate no: M151120. 
Permission to conduct the study was obtained from the Chief executive office at CHBAH, 
heads of department – Obstetrics & Gynaecology and Anaesthesiology. (Appendix C). All 
women in the study remain anonymous with each being allocated a specific study number. 
The data sheet only reflects the study number and data pertaining to the study. Details of 
the women were only available to the researcher and the supervisors. Data will be kept 
secure for 5 years. 
The study adheres to South African Good Clinical Practice Guidelines and the Declaration 
of Helsinki. 
3.11 Funding 
The only costs incurred were that of stationery and data capturing, which were borne by 
the researcher. 
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4.0 RESULTS 
There were 9305 women who delivered between 01/05/2015 and 31/10/2015, of which 302 
women received intrapartum epidural analgesia. The incidence of intrapartum epidural 
analgesia was 3.24% or 32/1000. 
The medical records of 19 women were excluded from analysis as the records for 2 
women were not found, 5 were booked for elective caesarean sections and 3 were 
transferred out to another hospital and outcomes not known. There was also 1 epidural 
placement failure and the procedure abandoned, and eight women with incomplete 
records. This resulted in the analysis being conducted on a sample size of 283 women. 
 
4.1 Maternal Characteristics 
 
Table 2 Maternal Characteristic 
Variable 
Mean ±SD 
Median(range) 
Number (%) 
n=283 
Age in years 26.1 ±6.1 
Parity 0 (0-4) 
Gravidity 2 (0-6) 
 Black 279 (98.6) 
Race 
Coloured 1 (0.4) 
Indian 2 (0.7) 
White   1 (0.4) 
Gestational Age in Weeks at delivery 38.9 ±1.6 
HIV Seropositive 46(16.3) 
Cardiac disease in pregnancy 2 (0.7) 
Hypertensive disorders in pregnancy 17 (5.0) 
Epilepsy  1 (0.4) 
Asthma  5 (1.8) 
 
The maternal characteristics of the 283 women analysed are reflected in Table 2 above. 
The mean maternal age was 26.1 with a standard deviation of 6.5 years. The median 
parity and gravidity was 0 (range 0-4) and 2 (range 0-6) respectively. The mean 
gestational age at delivery was 38.9 ±1.6 weeks.  There were 46 (16.3%) women who 
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were HIV positive, all of whom were on antiretroviral therapy at delivery. There were 17 
(5%) women with pregnancy related hypertensive disorders, which included gestational 
hypertension and preeclampsia. There were also 2 (0.07%) women with cardiac diseases, 
1 (0.4%) with epilepsy and 5 (1.8%) asthmatics. Racial variation included, Black 279 
(98.6%), Coloured 1 (0.4%), Indian 2 (0.7%) and White 1 (0.3%).  
4.2 Maternal outcomes and complications  
 
Table 3 Maternal Outcomes and complications associated with epidural 
analgesia 
Variable   
Mean ±SD 
Number(%) 
Median (range) 
n=283 
Blood pressure 
Baseline MAP  93 (76-120) 
MAP 15 minutes post epidural  77 (50 – 100) 
Women with change in MAP* 90 (31.8) 
Women with increase in MAP 3 (1.1) 
Women with decrease in MAP 87 (30.7) 
Heart rate 
Baseline heart rate 97 (80 -120) 
Heart rate 15 minutes post epidural 90 (60 – 140) 
Women with change in Heart Rate 39 (13.8) 
Women with increase in Heart Rate 30 (10.6) 
Women with decrease in Heart Rate 9 (3.2) 
Temperature  
Baseline temperature 37 (36.2 – 37.9) 
Temperature 15 minutes post epidural  37 (36 – 39) 
Women with change in Temperature** 3 (1.1) 
Complications  
No complications  235 (83.0) 
Hypotension  38 (13.4) 
Spinal Analgesia  1 (0.4) 
Pyrexia 2 (0.7) 
Failed Epidural  4 (1.4) 
Maternal respiratory Distress 1 (0.4) 
High Spinal  1 (0.4) 
Other  1 (0.4) 
 
* Any change in MAP not meeting the definition for hypotension. **Any change in temperature not meeting the 
definition of pyrexia. MAP= Mean arterial pressure 
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Table 3 and 4 reflects the maternal outcomes. Ninty women (31.8%) had a change in 
mean arterial pressure, where 87 (29.5%) had a decrease and 3 (1.1%) an increase in 
mean arterial pressure. The mean change in MAP pre and post epidural was a 30% ±12 
decrease from baseline. A change in heart rate was seen in 39 (13.8%) of the women, of 
which 30 (10.6%) experienced an increase and 9 (3.2%) a decrease in heart rate.  An 
increase in temperature was seen in 3 (1.1%) women, with no decrease noted. Of the 283 
women who received intrapartum epidural analgesia, 48 (17%) women experienced 
complications. These complications included: hypotension 38 (13.4%), spinal analgesia 1 
(0.4%), pyrexia 2 (0.7%), failed epidural 4 (1.4%), maternal respiratory distress 1 (0.4%) 
and high spinal 1 (0.4%). One women (0.4%) developed meningitis after being discharged 
with the epidural in situ. There was no associated mortality.  
Table 4 Epidural related complications based on Maternal Factors   
Variable Epidural Related Complications 
No complications Complications 
p value 
 
Mean ±SD 
Median(range) 
Number(%) 
Mean ±SD 
Median(range) 
Number(%) 
 n=235 n=48  
Age in years   26.2 ± 6.3 24.5 ±3.1 0.90 
Race     
Black  (279) 233 (99.1) 46 (95.3) 0.13* 
Indian (2) 1 (0.4) 1 (2.1) 0.31* 
White (1) 0 1 (2.1) 0.17* 
Coloured (1) 1 (0.4) 0 1.00* 
Baseline MAP  93.5 ±10 95.3 ±4.3 0.76 
MAP 15 minutes post epidural 80.5 ±12.8 74.1 ±8.2 <0.01 
Mean decrease in MAP 17.9% ±10.5 34.6 %±20.5 <0.01 
Baseline HR 96.5 ±14.1 87.5 ±10.3 0.59 
HR 15 minutes post epidural  92.0 ±16.3 102.7 ±16.3 <0.01 
Mean change in HR 17%±5.5 28%± 9.5 <0.01 
Comorbidities    
Gestational hypertension 9 (3.8) 1 (2.1) 1.00* 
Preeclampsia 5 (2.1) 0 0.60* 
Chronic hypertension 2 (0.9) 0 1.00* 
Cardiac 2 (0.9) 0 1.00* 
HIV 38 (16.2) 8 (16.6) 1.00* 
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*p value calculated using Fischer exact test MAP= Mean arterial pressure, HR = heart rate HIV= Human 
Immunodeficiency Virus 
 
Table 4 reflects maternal characteristics sub-divided according to epidural complications. 
The mean maternal age of women with epidural complications were 24.5 ±3.1 years, 
which was similar to that of women without complications; 26.2 ±6.3 years.  
Baseline mean arterial pressure and heart rate showed no significance in term of epidural 
complications nor did the presence of maternal co morbidities. The average decline in 
MAP of women with epidural complications was significantly higher than the decline in 
MAP in women with no complications (34.6% versus 17.9% respectively, p<0.05). A larger 
number of women with epidural complications had a significant increase in heart rate post 
epidural (28% versus 17%, p<0.05). None of the women who had adverse outcomes, had 
pre-eclampsia or cardiac disease.  
4.3 Labour associated factors 
 
4.3.1 Peripartum factors   
Table 5 Labour Outcomes
Variables  
Mean ±SD 
Number(%) 
n=283 
Prolonged latent phase of labour 69 (24.4) 
Poor 
progress of 
labour 
Pre epidural  96 (33.9) 
Pre and Post Epidural 84 (29.7 ) 
Post Epidural only 13 (4.6) 
Oxytocin usage for Augmentation of labour  97 (34.2) 
Second 
stage of 
labour 
Mean Duration 63 ±33.3 
Duration > 60minutes 76 (26.9) 
Duration >120 minutes 14 (4.9) 
Average duration in primigravidas 79 ±39.1 
Average duration in multigravidas in minutes 40 ±35 
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The peripartum findings are described in Table 5. Sixty-nine (24.4%) women had a 
prolonged latent phase of labour, of which none received intrapartum epidural analgesia 
during the latent phase of labour. There were 193 (65.4%) women with poor progress of 
labour, 96 (33.9%) of whom had poor progress prior to epidural analgesia, 84 (29.7%) had 
poor progress pre and post epidural and 13 (4.6%) women with poor progress post 
epidural only.  
Oxytocin for augmentation of labour was used in 97 (34.3%) of the women. 
The average duration of the second stage of labour was 63 minutes ± 33.3, with a mean 
duration of 79 minutes ± 39 in primigravidas and 40 minutes±35 in multigravidas. Seventy-
six (26.9%) women had a prolonged second stage beyond 60 minutes, with 14 (4.9%) 
women having a second stage duration greater than 120 minute.
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Table 6 Maternal and labour factors associated with prolonged second stage 
of labour 
Variable 
Duration of second 
stage of labour 
<60 minutes 
Mean ±SD 
Median(range) 
Number(%) 
Duration of second 
stage of labour  
>60 minutes 
Mean ±SD 
Median(range) 
Number(%) 
p value 
 N= 207 N= 76  
Age in years 27.8 ±5.9 24.0 ±5.6 <0.01* 
Parity 2 0 <0.01* 
Comorbidities    
gestational hypertension 3 (1.4) 1 (1.3) 1.00** 
preeclampsia 2 (0.9) 0 1.00** 
cardiac 2 (0.9) 0 1.00** 
HIV 21 (10.1) 10 (13.2) 0.52* 
Decrease in MAP mmhg 25.9 ±14.7 19.8 ±13.8 0.71* 
Complications    
hypotension 12 (5.8) 14 (18.4) <0.01* 
Use of oxytocin for 
Augmentation of Labour  70 (33.8) 46 (60.5) 0.05* 
Duration of oxytocin in 
minutes 113 ±160 213 ±150 0.05* 
Poor Progress of Labour  33 (15.9) 22(28.9) 0.12* 
*p value calculated using Annova. **p value calculated using Fischer exact test. HIV= Human 
Immunodeficiency virus, MAP= Mean arterial pressure. 
Maternal and labour factors sub-divided by evidence of prolonged second stage of labour 
are reflected in Table 6.  The average age of women with prolonged second stage of 
labour was 24 ±5.6 years vs. 27.8±5.9 years in those women who did not have a 
prolonged second stage of labour p<0.05. 
A statistically significant difference was noted in duration of the second stage with respect 
to parity of the women. Significantly more women of zero parity had longer durations of 
the second stage of labour, p <0.05. The average duration of oxytocin was higher in 
women with prolonged second stage than those without, 224 minutes vs. 113 minutes, but 
not of significant value. There was no significant difference noted amongst the groups with 
respect to comorbidities and change in MAP. However the presence of hypotension as a 
complication of the epidural analgesia showed significance in relation to prolonged 
second stage of labour. 
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4.3.2 Mode of delivery   
Table 7 Mode of delivery 
Variable 
Mean ±SD 
Number(%) 
n=283 
 NVD 142 (50.2) 
 Instrumental delivery 23 (8.1) 
 Caesarean Section  118 (41.7) 
 
Indication for 
Caesarean 
Section 
Other 7 (2.5) 
Prolonged LPL 2 (0.7) 
Poor progress of labour 21 (7.4) 
Fetal distress 65 (23.0) 
APH 5 (1.8) 
Failed assisted delivery 0 
Delayed second stage of 
labour 7 (2.5) 
Cephalopelvic Disproportion 10 (3.5)  
NVD = Normal vaginal delivery, LPL= Latent phase of labour, APH= Antepartum hemorrhage. 
 
Table 7 reflects the mode of delivery as well as the indications for caesarean deliveries. 
Of the 283 women, 142 (50.2%) had normal vaginal deliveries, 23 (8.1%) women had 
assisted vaginal deliveries and 118 (41.7%) delivered via caesarean section.  
Indications for caesarean sections included: prolonged latent phase of labour 2 (1.7%), 
poor progress of labour 21 (7.4%), fetal distress 65 (23%), antepartum haemorrhage 5 
(1.8%), delayed second stage of labour 7 (2.5%) and cephalopelvic disproportion 10 
(3.5%).  
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Table 8 Mode of delivery stratified by maternal and fetal characteristics pre 
and post epidural. 
Variable 
Mode of Delivery 
NVD 
 
 
Mean ±SD 
Median(range) 
Number(%) 
n=142 
C/S 
 
 
Mean ±SD 
Median(range) 
Number(%) 
n=118 
Assisted 
Vaginal 
Delivery 
Mean ±SD 
Median(range) 
Number(%) 
n=23 
p-
value 
Age 26.4 ±6.3 25.8 ±6 24.9 ±5 0.49* 
Parity 1 (0-4) 1 (0-4) 0 (0-4) 0.09* 
Gravidity 2 (0-4) 2 (0-4) 1 (0-4) 0.07* 
Baseline MAP 92.9 ±11.9 94.2 ±11.6 91.7 ±11.4 0.50* 
Baseline HR 95.3 ±14.6 96.4 ±13.4 100.6 ±17.5 0.24* 
Decrease in MAP 
(mmHG) 18.6%±20.09 23.9% ±20.13 29.6% ±27.42 0.01* 
Change in HR (bpm) 11% ±4.4 20% ±5.6 5.6% ±7.8 0.00* 
Interepidural 
complications      
hypotension 16 (11.3) 14 (11.9) 8 (34.8) 0.00** 
Spinal Analgesia 0 1 (0.8) 0 0.50** 
Failed Epidural 0 3 (2.5) 1 (4.3) 0.06** 
fever 0 2 (1.7) 0 0.50** 
Maternal distress 0 1 (0.8) 0 0.50** 
Use of Oxytocin 94 (66.2) 77 (65.3) 14 (60.9) 0.90* 
Total duration of Oxytocin 147 ±247 169 ±283 237 ±291 0.30* 
*p value calculated using Annova. **p value calculated using Fischer exact test.  
Mode of delivery stratified by maternal characteristics, epidural and labour factors are 
reflected in Table 8.  Maternal factors, such as age, parity and gravidity show no statically 
significance in terms of mode of delivery.  
A significantly higher decline in MAP was noted in women who delivered via caesarean 
section and assisted vaginal delivery in comparison to the NVD group, p value<0.05, 
together with an increase in heart rate greatest within the caesarean section deliveries.  
It is also noted that majority of women with epidural complications (majority been 
hypotension) deliver via caesarean section (65% vs 45%, p<0.05). Use of oxytocin and 
the duration thereof shows no statically value with regard to mode of delivery. 
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4.4 Fetal and neonatal associated factors 
 
4.4.1 CTG changes  
Table 9 CTG changes post epidural  
Variables 
CTG PRE EPIDURAL 
Number(%) 
n= 283 
CTG POST EPIDURAL 
Number(%) 
n=283 
Reactive  266 (94.3) 204 (72.1) 
Suspicious 14 (5) 76 (26.8) 
Pathological  2 (0.7) 2 (0.7) 
 
Every woman in labour had intermittent CTG tracings done. There were a total of 266 
(94.3%) women who had reactive tracings prior to the placement of the epidural. Of the 
remaining women: 14 (5%) had a suspicious tracing, which was represented by a single 
deflection from the norm in baseline, variability, or presence of decelerations and 2 (0.7%) 
women with pathological tracings. CTG tracings done immediately after placement 
showed a decrease in the number of reactive tracings from 266 (94.3%) to 204 (72.1%). 
There was also an increase in the number of suspicious tracings from 14 (5%) to 76 
(26.8%) with no changes in the number of pathological tracings. The variables included, 
changed in heart rate 19(30.6%), change in variability 10 (16.1%), and new onset 
decelerations 2 (3.2%). 
Table 10.1 CTG pre and post epidural stratified by Apgars<7 
Variables Neonatal Apgar score<7 at birth 
CTG pre epidural 
placement 
CTG post epidural placement  
Reactive Suspicious p valve 
Reactive n= 266 9 10 0.13* Suspicious n= 14 0 4 
*p value calculated using Fischer exact test 
Table 10.2 CTG pre and post epidural stratified by Apgars>7 
Variables Neonatal Apgar score>7 at birth 
CTG pre epidural 
placement 
CTG post epidural placement  
Reactive Suspicious p valve 
Reactive n= 266 194 52 <0.01* Suspicious n=14 0 9 
*p value calculated using Fischer exact test 
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Table 10.1 and 10.2 reflects changes in CTG pre and post epidural stratified by Apgar 
score at birth. Of the neonates that were born with Apgar scores <7, there were 9 (3.2%) 
traces which were reactive pre and post epidural, 10 (3.5%) that had changed from 
reactive to suspicious and 4 (1.4%) that remained suspicious post epidural (p value<0.12). 
Of all the neonates with Apgar scores >7, 194 (68.6%) were reactive pre and post 
epidural, 52 (18.4%) changed from reactive to suspicious and 9 (3.2%) that were 
suspicious pre and post epidural (p value<0.05). 
4.4.2 Neonatal outcomes  
Table 11 Neonatal outcomes 
Variable Number (%) n = 283 
Apgar score at 
Birth 
Apgar score < 7 23 (8.1) 
Apgar score > 7 258 (91.2) 
Neonatal  
outcome   
Born Alive 278 (98.2) 
No Adverse Outcome 269 (95) 
Adverse outcome 
Birth Trauma  0 (0) 
FSB 2 (0.7) 
ENND 2 (0.7) 
Cephalohaematoma  3 (1.1) 
HIE 5 (1.8) 
Required 
Admission to 
TICU 
Apgars<7 at 10 minutes  4 (1.4) 
Respiratory Distress 2 (0.7) 
Neonatal Sepsis  1 (0.4) 
FBS= fresh stillbirth, ENND= early neonatal death, HIE = hypoxic ischemic encephalopathy, TICU= 
transitional intensive care 
The neonatal outcomes can be seen in Table 11. Of the 283 neonates delivered, 278 
(98.2%) neonates were born alive, with 258 (91.2%) having Apgar scores of >7 and 23 
(8.1%) Apgar scores <7. Two hundred and sixty nine (95%) neonates were born with no 
adverse outcomes and 12 (4.2%) were born with adverse outcomes. There were 2 (0.7%) 
were intrauterine deaths not related to labour. The adverse outcomes were as follows: 
2(0.7%) early neonatal deaths, 3 (1.1%) cephalohaematomas, 5 (1.8%) neonates with 
hypoxic ischemic encephalopathy and 2 (0.7%) fresh stillbirths. The cause of the early 
neonatal deaths was attributed to severe respiratory distress and neonatal sepsis. Seven 
neonates required admission to transitional intensive care unit (TICU), 4 (1.4%) for Apgar 
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scores<7 at 10 minutes, 2 (0.67%) for respiratory distress and 1 (0.3%) for neonatal 
sepsis. There were no admissions to the neonatal intensive care unit. 
Table 12 Neonatal outcomes reflected by mode of delivery 
Variable 
Mode of Delivery 
NVD 
 
 
Mean ±SD 
Number(%) 
n=142 
C/S 
 
 
Mean ±SD 
Number(%) 
n=118 
Assisted 
Vaginal 
delivery 
Mean ±SD 
Number(%) 
n=23 
p-value 
Apgar scores      
<7 7 (4.9) 15 (12.7) 1 (4.3) 0.30* 
>7 133 (93.7) 103 (87.3) 22 (95.7) 0.30* 
Fetal Outcomes     
Alive  140 (98.6) 112 (94.9) 20 (86.9) 0.25* 
Cephalohaematoma  0 0 2 (8.7) 0.30* 
FSB 2 (1.4) 0 0 0.24* 
ENND 0 2 (1.7) 0 0.25* 
HIE 0 4 (3.4) 1 (4.3) 0.25* 
*p value calculated using Fischer exact test. NVD= Normal vaginal delivery, C/S= Caesarean section, FBS= 
fresh stillbirth, ENND= early neonatal death, HIE = hypoxic ischemic encephalopathy. 
 
Table 12 reflects fetal outcome based on mode of delivery. As already noted 142 (50.2%) 
women delivered via NVD and of those 133 (93.7%) neonates were born with Apgar 
scores >7 and 7 (4.9%) with Apgar scores <7, with 2 (1.4%) neonatal adverse outcomes. 
Of the 118 (41.7%) neonates born via caesarean section 15 (12.7%) had Apgar scores <7, 
103 (87.3%) with Apgar scores >7 and 6 (11.1%) neonates with adverse outcomes. There 
were 23 (8.1%) assisted Vaginal deliveries, 1 (4.3%) neonate had an Apgar score<7, 22 
(95.7%) had Apgar scores >7 and there were 3 (13%) adverse outcomes. In terms of 
Apgar scores and fetal outcome, mode of delivery reflected not statistic benefit or risk.  
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Table 13 Fetal outcome stratified by maternal, epidural and labour outcomes 
Variable 
FETAL OUTCOME 
No adverse 
outcome 
 
Mean ±SD 
Median(range) 
Number(%) 
n=269 
Adverse outcome 
 
 
Mean ±SD 
Median(range) 
Number(%) 
n=12 
P-value 
Maternal Age 26.1 ± 6.0 23.1 ±2.0 0.19 
Parity 1 (0-2) 0 (0-1) 0.16* 
Gestational Age 38.9 ±1.5 38.7 ±2 0.12 
Decrease in MAP 21.9 ±21.2 14.7 ±10.9 0.56 
Interepidural complications    
No complications 224 (83.2) 8 (66.7) 0.95 
Hypotension 36 (13.4) 4 (33,3) 0.07 
Spinal Analgesia 1 (0.4) 0 1.00* 
Failed Epidural 4 (1.5) 0 1.00* 
Fever 2 (0.7) 0 1.00* 
High spinal 1 (0.4) 0 1.00* 
Maternal respiratory 
distress 1 (0.4) 0 1.00* 
Mode of Delivery    
NVD  140 (52) 4 (33.3) 
0.33* Caesarean Section  107 (39.8) 7 (58.3) 
Assisted Vaginal deliveries 22 (8.2) 1 (8.3) 
Duration of Oxytocin use 170±271 90 ±200 0.63 
Duration of second stage of 
Labour  40 ±39.3 68 ±51 0.56 
*p value calculated using Fischer exact test. 
 
Table 13 reflects the fetal outcomes based on maternal, epidural and labour factors. 
Despite the average maternal age in pregnancies with adverse outcomes being lower 
than those of pregnancies with no adverse outcomes it was of no significant value ( 23.1 
vs 26.1; p value >0.05). Neither parity, gravidity nor gestational age showed any 
significance in terms of fetal outcome. A greater decrease in MAP was noted in women 
who delivered neonates without adverse outcomes in comparison to those with adverse 
outcomes (21.9 vs 14.7; p value >0.05)  
The majority of women, 45 (16.8%) who experienced intra epidural complications, 
delivered neonates without any adverse outcomes vs 4 (1.4%) with adverse outcomes. 
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The most common complication experienced by the study population was that of 
hypotension, and despite having a larger number of adverse fetal outcomes in women 
who developed hypotension, it reflected no statistical significance. 
 
5.0 DISCUSSION  
The percentage of women receiving intrapartum epidural analgesia during the study 
period was 3.24%, which is below the reported rates in developed countries. In a 2012 
audit of epidural services at a tertiary hospital in the Western Cape, the rate of intrapartum 
epidural analgesia was 2.2%, whilst in the United Sates of America and European 
countries its 50% and 25%, respectively.1,16 The epidural rate of 3.24% is only applicable 
to CHBAH, and does not reflect incidences of surrounding tertiary institutes. The limited 
usage of intrapartum epidural in developing countries in comparison to developed 
countries reflects the wide variation in health care provision globally.  
In a study performed in the Western Cape, the low epidural rate of 2.2% was attributed to 
limited time and a shortage of staff, as there was only one anaesthesiologist for both 
epidural and emergency services.16 During the 6-month period of this study however, 
there was a dedicated anaesthesiologist for epidural services, and the low rates were 
mostly due to reservations from women and medical staffs based on perceptions that 
epidural analgesia prolongs the first and second stage of labour.  This finding is in 
keeping with studies performed in other developing countries, suggesting that 
reservations from medical personal, low socioeconomic status and lower educational 
levels of women contribute to lower intrapartum epidural use.16,17;18  
The mean maternal age of patients in this study was 26.1 years. This is in keeping with 
the reported ranges of 21.2 to 32.7 years.41,42,43 The mean gestational age at the time of 
delivery was 38.9 weeks, and therefore allowed for adequate assessment of fetal outcome, 
alleviating complications of prematurity. The median parity within this study was 0, in 
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keeping with studies conducted by Dickson J,et al. and Halpern S,et al. who reported that 
nulliparous women are more likely to request epidural analgesia.40,41 Suggesting that 
nulliparous women in who the primary indication for caesarean sections is fetal distress 
and dystocia are more likely to choose epidural analgesia.  
5.1 Maternal Outcomes  
Epidural complications were seen in 48 women, with a complication rate of 17%, in 
keeping with the complication incidence of 14,1% globally as reflected in a recent ACOG 
Practice Bulletin.3   These complications consisted of 16.3% minor complications and 0.3% 
major complications with no recorded mortality. Scott D,et al. and others, despite having a 
larger cohort found a similar incidence of severe long-term complication rates.27,28 
Maternal factors were stratified against presence of complications, and no clear risk profile 
was identified, and therefore benefit of epidural analgesia outweighs the potential 
associated risk. 
The most common complication was that of hypotension 13.4%, with an average decline 
in mean arterial pressure of 30%. This is slightly higher than the global incidence of 9% 
but in keeping with local data where the incidence was reported at 13.5%.16, 31 The decline 
in blood pressure and subsequent hypotension (MAP<65mmHg or decline more than 
10%), was not associated with age, baseline MAP, race or presence of comorbidities and 
occurred despite fluid preloading of the women.  Kinsella S,et al., Dryer R,et al. and 
Hofmyer G,et al., reported similar incidence of hypotension with epidural use despite pre 
loading with fluids.32,33,34 These trials mentioned above were similar in nature as each 
used 1000ml of crystalloid fluid as their preloading. In this study no standard protocol was 
available and different anesthesiologists used different fluids, including crystalloids and 
colloid at differing amount. However due to the impact of maternal hypotension on 
placental blood flow and the transient risk of fetal heart rate decelerations measures need 
to be instituted early to correct this potential complication.   
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The incidence of pyrexia within this study was 0.6%, and demonstrated no change in 
baseline temperature post epidural. The majority of the women were nulliparous. 
Apantaku O,et.al conducted a study assessing risk of pyrexia in nulliparous labour and 
reported a 33% incidence.36 Anim-Somuah M,et al. reported a three times greater 
incidence of pyrexia associated with epidural use.1 While this study consisted of both 
nulliparous and multiparous women, there was no control group to assess relative risk 
between epidural use versus non-epidural use. Also this study cohort was smaller than 
Anim-Somuah, et al. 258 vs 150000 respectively. Therefore the incidence of pyrexia with 
epidural use cannot be commented on.  
The incidence of post epidural headaches was 1% in this study and the global incidence 
has been shown to range from 1.3% to 30%.3 
Other complications included failed epidural of 1.4%, which was lower that the reported 
incidence of 13.5%.28 Apart from a single episode of a high spinal which was adequately 
managed, with complete recovery there was no associated maternal morbidity or mortality 
recorded.  This is in keeping with the proposed rarity of major fatal complications 
associated with epidural as discussed in a French survey. 27,28 
 
5.2 Labour Outcomes  
Ninety-six (33.9%) women had features of poor progress of labour prior to the placement 
of the epidural catheter. This number decreased to 84 (29.7%) after epidural placement. 
Thirteen (4.6%) women had features of poor progress of labour only after the placement 
of the epidural catheter. These findings are similar to the meta analysis conducted by 
Anim-Somuah,et al. which concluded that epidural analgesia has no significant effect on 
the duration of the first stage of labour with a mean difference of 13.66 minutes and a 
confidence interval of 95%.1 
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There were 97(32.8%) women who received oxytocin for augmentation of labour, similar 
to the international findings of 40% incidence of oxytocin use related to epidural 
analgesia.19 This study, while consisting primarily of nulliparous women did not compare 
the use of augmentation of labour pre and post epidural analgesia.  
Lewis,et al. found that 60% of women who request epidural analgesia had oxytocin 
augmentation of labour commenced prior to epidural placement (95%CI 0.33-0.42).47 
Similar findings have been reported that augmentation of labour is a common practice in 
nulliparous women who are more likely to request analgesia.7,19 
Therefore the relationship of epidural analgesia and the incidence of oxytocin use is an 
associative rather than a causal one.  
There were a total of 142(50.2%) women that had a normal vaginal delivery. There were 
118 women that delivered via caesarean section and 23 that had assisted vaginal 
deliveries. The incidence of caesarean sections and assisted vaginal deliveries was 
41.7% and 8.1% respectively.  The incidence of caesarean section deliveries at CHBAH is 
38.5%, which is only slightly lower than the incidence found within this study. Within the 
study cohort 50.2% delivered vaginally and 41.7% by caesarean section. A regression 
analysis was not performed on the data and therefore a causation relationship could not 
be established between epidural analgesia and risk of caesarean section. The statistic in 
table 7 reflects no relative risk of caesarean section deliveries with epidural analgesia. 
These finding are in keeping with data performed by Anim-Somuah,et al. who reported a 
relative risk of 1.07 with a confidence interval of 95%.1 Dickson, et al. reported that when 
given the choice of analgesic regime, obstetric factors like painful labour, oxytocin usage 
and cervical dystocia are more likely to influence women’s choice.40 Similarly, in the 
CHBAH cohort, women requested epidural analgesia.  
Of the 118 women who delivered via caesarean section the main indication (55%) was 
that of fetal distress. Epidural analgesia is associated with CTG changes post epidural in 
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particular changes in baseline fetal heart rate, as a result of either maternal hypotension 
or uterine hypotonicity 40,50,51 A significantly higher decrease in MAP was noted in women 
who received epidural analgesia and delivered via caesarean section in comparison to the 
NVD group, p value<0.05.  This resultant hypotension and therefore fetal heart rate 
changes could account for the higher incidence of caesarean sections. Studies however 
have shown that despite prolonged episodes of fetal bradycardia, there were no 
associated adverse neonatal outcomes.50,51,52 One study looked at CTG changes post 
epidural analgesia, in women who had hypotension post epidural placement versus 
women with intravenous analgesia. A 24% increase in variable and late deceleration was 
noted within the epidural group, but the neonatal outcomes were similar within the two 
groups.  Most attending physicians opted for conservative measures and this resulted in 
no increase incidence of caesarean section rates. 51 
Therefore any changes in CTG post epidural analgesia may be treated conservatively if 
there is no evidence of a pathological trace pattern, though this is not part of the protocol 
at CHBAH and most suspicious tracing post epidural was managed actively and a 
caesarean section was performed. This could be a causal effect to the relative increase in 
caesarean section rates seen in this study however no formal conclusion can be drawn as 
no statical evaluation was performed.  
There were 23(8.1%) women who delivered via assisted vaginal delivery, all of which 
were vacuum assisted deliveries. This is out of keeping with the relative increased risk 
associated with epidural analgesia and assisted vaginal delivery. 1,38,40,41,42 An explanation 
for the decreased incidence of assisted vaginal deliveries could be that CHBAH, is a low 
resource academic setting and at times there is a lack of availability of vacuum devices 
and/or poor skills of attending physicians and therefore decreased use of assisted delivery 
methods. Poor documentation of assisted vaginal deliveries could also explain the 
relatively low incidence, however this study did not include such confounding factors.  
The average duration of the second stage of labour was 63 minutes ±33, which is contrary 
to studies that suggest that epidural analgesia prolongs the second stage of labour by an 
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average of 25 minutes.1,38,40,41,42 However when the population group was divided into 
primigravid versus multigravid women, the average duration of the second stage was 79 
minutes ±39 and 40 minutes±35, respectively. This correlates with findings by Zhang who 
observed that the median duration of the second stage of labour in nulliparous versus 
multiparous women with epidural analgesia was 70 minutes and 35 minutes 
respectively.43 
The incidence of prolonged second stage of labour beyond 60 minutes was 26.9%, which 
is slightly higher than the general prevalence of 20% of all live births irrespective of 
analgesia.49   This could be explained by the fact that the majority of the study population 
was nulliparous women at term, which in itself is a risk factor for a protracted second 
stage of labour.38   This is in accordance with the risk stratification that showed a longer 
duration of the second stage of labour within the nulliparous population. It was always 
shown that the mean age of women who had prolonged second stage of labour was 
younger than those who had a second stage less than 60 minutes, 24.0 years vs. 27.6 
years.  
In terms of epidural complications, in particular hypotension and its effect on the second 
stage of labour, no studies could be identified and therefore requires further investigation 
to draw a formal conclusion.  
5.3 Fetal and neonatal outcomes  
There were 62 women who had changes in the CTG pattern from reactive to suspicious 
post epidural analgesia in this study. Of those 10 (3.5%) were born with an Apgar score 
<7 (p value>0.23), while 52(18.4%) had Apgars>7 (p value<0.05). This may be attributed 
to the low positive predictive value of CTG tracings. However women in labour who have 
received epidural analgesia should still receive CTG monitoring, as it is still the best 
available tool to anticipate poor fetal outcomes. 
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There were a total of 258 (91.2%) neonates born with Apgars >7 and 95% of them had no 
adverse outcome. This is in keeping with studies performed on neonatal outcomes of 
women who receive epidural analgesia intrapartum.1,21,51  It has also been shown that 
despite changes in CTG patterns post epidural analgesia, neonates of mothers who 
received epidural analgesia had fewer Apgar scores <7 and decreased requirements for 
naloxone.51,52 
6.0 LIMITATIONS 
Further studies would need to be done to assess the views of medical professionals on 
offering epidural services to women in labour and the impact of such views. The study 
cohort consisted primarily of Black women (98.6%), but cannot be used as a 
representation of racial variation in epidural use locally, as it does not clearly illustrate use 
in other races within South Africa. No studies were identified that showed any preference 
to epidural usage based on race within the South African population.  
7.0 CONCLUSION  
An evaluation of the intrapartum epidural analgesia service at the CHBAH yielded results 
that are beneficial to women and their neonates compared to the associated risk of 
intrapartum epidural analgesia. The maternal complication rate was 17% with no 
associated morbidity or mortality. There was no increased incidence of caesarean section 
deliveries considering that 50.2% of women had normal vaginal deliveries and 41.7% 
delivered via caesarean section, with mode of delivery proving no benefit or risk to the 
neonate. Despite the incidence of hypotension and CTG changes post epidural analgesia 
91.2% of the neonates were born with Apgar scores > 7 and an adverse neonatal 
outcome rate of 4.2%. 
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APPENDIX A: DATA SHEET 
Maternal factors  
Study no  
Age in years   
Parity  
  
Booking Status booked 1 
 unbooked 0 
   
Gestational age at 
booking in weeks 
  
Gestational age at 
delivery in weeks 
  
   
Co morbidities Diabetes 1 
 Gestational 
hypertension  
2 
 Preeclampsia 3 
 Chronic 
hypertension 
4 
 Cardiac 
disease 
5 
 HIV 6 If positive  
CD4 count 
   ViralLoad 
(copies) 
   Anteretroviral 1 
    0 
    2 
 Epilepsy 7 
 Other 1 8 
 Other 2 9 
Race  Black 1 
 Coloured 2 
 Indian  3 
 White 4 
 Other 5 
Last recorded 
weight on 
Antenatal card 
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Epidural Factors  
Baseline Observations Blood pressure  systolic    
  diasystolic    
  Hypertension  yes 1 
    no 0 
 Heart rate     
 Respiratory rate     
 Temperature     
      
Post epidural Observation Blood pressure systolic    
  diasytolic    
  hypertension  yes 1 
    no 0 
  hypotension  yes 1 
    no 0 
 Heart rate     
 Respiratory rate     
 Temperature     
     
Intra epidural significant 
event  
Blood pressure  1 increase 1 
   decrease 0 
 Heart rate  2 Increase  1 
   decrease 0 
 temperature 3 Increase  1 
   decrease 0 
 other 4   
ASA Status     
     
Difficulty with placement yes 1   
 no 0   
     
Level of epidural L3/L4 1   
 L4/L5 2   
     
Density of block Sensory only 1   
 Motor only 2   
 Sensory and motor 3   
Other medication yes Name/s 
 no  
Complications Hypotension 1 
 Spinal analgesia 2 
 Failed Epidural 3 
 Fever 4 
 Headaches  5 
 Respiratory distress 6 
 High Spinal  7 
 Other  8 
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Labour factors  
Total duration of labour in 
hours 
 
  
Total duration of latent 
phase of labour in hours  
 
  
Total duration of active 
phase of labour in hours 
 
  
Rate of cervical dilatation 
post epidural placement  
<1cm/hr 1 
 1-1.5cm/hr 2 
 >1.5cm/hr 3 
   
Use of Syntocinon Yes  1 Duration in 
hours 
 
   Duration pre 
epidural 
 
   Duration post 
epidural 
 
 No 0   
     
Duration of second stage of 
labour in minutes 
 
 
Delivery factors  
Mode of delivery NVD 1   
 Caesarainsection  2   
 Instrumental delivery 3 Vacuum delivery 1 
   Forcep delivery 2 
   episiotomy 3 
Indication for caesarain 
section 
Prolonged latent 
phase of labour 
1 
 Poor progress 2 
 Fetal distress 3 
 Antepartum 
haemorhage 
4 
 Failed operative 
delivery 
5 
 Delayed second stage 
of labour  
6 >1hour 1 
   1-2 hours 2 
   >2hours 3 
 Cephalopelvic 
disproportion 
7 
 Other 1  8 
 Other 2 9 
   
Complications  PPH 1 500-1000ML 1 
   >1000ML 2 
   Blood transfusion 
required 
3 
 TAH 2 Atonic Uterus 1 
   PPH 2 
   Cervical tear  3 
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   Other  4 
 Vaginal tear 3 NVD 1 
   Vacuum delivery 2 
   Forceps delivery 3 
 Other  4   
 
Fetal factors  
Antepartum fetus 
alive 
yes 1 
 no 0 
Corticosteroids 
required 
yes 1 Received 2 
doses of steroids 
1 
   Received 1 
doses of steroids 
0 
 No 0 
Fetal heart rate 
prior to epidural  
 
 
Fetal heart rate 
post epidural 
 
   
Change in fetal 
heart rate 
yes 1 
 no 0 
   
NST prior to 
epidural 
Reactive 1 Baseline  1 
 Suspicious 2 Variability 2 
 Pathological 3 Accelerations  yes 1 
    no 0 
   Decelerations yes 1 
    no 0 
   type  
NST after epidural Reactive 1 Baseline   
 Suspicious 2 Variability  
 Pathological 3 Accelerations  yes 1 
    no 0 
   Decelerations yes 1 
    no 0 
   type  
NST during the 
second stage of 
labour 
Reactive 1 Baseline   
 Suspicious 2 Variability  
 Pathological 3 Accelerations  yes 1 
    no 0 
   Decelerations yes 1 
    no 0 
   type  
     
Birth weight in 
grams 
 
Apgars at 1 minute <7 1 
 >7 2 
   
Fetal Outcomes  Alive  1 
 Cephaloha 2 
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emotoma 
 Birth trauma 3 
 MSB 4 
 FSB 5 
 Hypoxic ischemic 
encephalopathy 
6 
Neonatal outcomes Early neonatal 
death 
yes 1 No of days alive  
    Cause of death  
  no 0 
 Neonatal ICU 
admission 
yes 1 Duration of stay  
    Outcome  
  no 0   
  TICU admission yes 1 Duration of stay  
    Outcome  
  no 0   																				
	 55	
APPENDIX B: ETHICS CLEARANCE FORM 
 	
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
	 56	
APPENDIX C: PERMISSION LETTERS 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
	 57	
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
	 58	
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
	 59	
APPENDIX D: CANDIDATE SUBMISSION FORM 
CERTIFICATE OF SUBMISSION FOR EXAMINATION OF MASTERS RESEARCH REPORT / 
DISSERTATION OR PHD THESIS SIGNED BY HIGHER DEGREES CANDIDATES 
Full name VENESHREE PADAYACHEE 
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Title of submitted Research Project:.Pregnanacy outcomes in women receiving intrapartum epidural 
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2. I hereby submit my Masters (research report) / Masters (dissertation) / PhD thesis  for 
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(Select whichever is applicable) 
3. I have checked all copies of my research report / dissertation / thesis and declare that no 
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4. I have submitted 2(TWO) bound copies and 1 (ONE) copy on CD. 
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